Amgen
Trade Amgen 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About AMGN
Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K.
AMGN Key Statistics
Stock Snapshot
The current Amgen(AMGN) stock price is $440.25, with a market capitalization of 238.01B. The stock trades at a price-to-earnings (P/E) ratio of 27.47 and offers a dividend yield of 2.22%.
On 2026-08-26, Amgen(AMGN) stock traded between a low of $438.24 and a high of $445.16. Shares are currently priced at $440.25, which is +0.5% above the low and -1.1% below the high.
The Amgen(AMGN)'s current trading volume is 592.06K, compared to an average daily volume of 2.45M.
During the past year, Amgen(AMGN) stock moved between $269.77 at its lowest and $447.03 at its peak.
During the past year, Amgen(AMGN) stock moved between $269.77 at its lowest and $447.03 at its peak.
AMGN News
In August 2026, TScan Therapeutics disclosed that Amgen elected to terminate their May 2023 Research Collaboration and License Agreement focused on Crohn's dise...
Amgen Inc (AMGN) announced an update on their ongoing clinical study. Unlock powerful investing tools with TipRanks Premium to make smarter, more confident inv...
Key Points Invesco Nasdaq Biotechnology ETF has a significantly lower expense ratio and double the dividend yield of VanEck Biotech ETF. VanEck Biotech ETF ma...
Analyst ratings
49%
of 35 ratingsMore AMGN News
Amgen Inc (AMGN) announced an update on their ongoing clinical study. Unlock powerful investing tools with TipRanks Premium to make smarter, more confident inv...
Advertisement Analyst moves put Amgen in focus Amgen (AMGN) is back on investors’ radar after Argus lifted its price target to $460 from $375 while keeping a...
Piper Sandler analyst David Amsellem raised the firm’s price target on Amgen (AMGN) to $457 from $427 and keeps an Overweight rating on the shares. The firm say...
Which Drugmaker Stock Has Dominated in 2026: Merck, Pfizer, or Amgen? By David Moadel Published Aug 19, 3:20PM EDT Quick Read Merck surged 44% YTD, topping Am...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.